Ambrisentan tablets 2.5 mg “SAWAI” by Sawai Pharmaceutical contain ambrisentan, indicated for the treatment of pulmonary arterial hypertension (PAH) (YJ code: 2190031F1040, standard: 2.5 mg 1 tablet).
Ambrisentan tablets 2.5 mg “SAWAI”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
